Search - tctmd.com

Displaying 101 - 120 of 4168

Sort: Relevancy | Date

Presentation TCT 2025

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

Presenter: Luca Arzuffi

October 27, 2025

Presentation TCT 2025

TCT 46: Transcatheter Delivery of World’s Smallest Leadless Pacemakers for Cardiac Resynchronization Therapy

Presenter: Charles Stark

October 27, 2025

Presentation TCT 2025

Percutaneous Transseptal Transcatheter Mitral Valve Replacement using a Dedicated Balloon Expandable Valve: 1 Year Outcomes from the ENCIRCLE Trial using the SAPIEN M3

Presenter: David Daniels

October 27, 2025

Presentation TCT 2025

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Priyesh Thakurathi

October 27, 2025

Presentation TCT 2025

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Presenter: Paul Sorajja

October 27, 2025

Presentation TCT 2025

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

Presenter: Ritu Yadav

October 27, 2025

Presentation TCT 2025

TCT 717: Transcaval Transcatheter Aortic Valve Replacement: Safety and Feasibility in Routine Practice “The Vigo Experience”

Presenter: José Antonio Baz Alonso

October 27, 2025

Presentation TCT 2025

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

TCT 36: Mid-term Outcomes of Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Replacement

Presenter: Konstantinos Stathogiannis

October 27, 2025

Presentation TCT 2025

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

Presenter: Frédéric Beaupré

October 27, 2025

Presentation TCT 2025

TCT 38: Anemia Predicts Outcomes After Transcatheter Tricuspid Interventions

Presenter: Emma Johns

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

TCT 39: Hypo-Attenuated Leaflet Thickening After Transcatheter Tricuspid Valve Replacement: A Proposed Severity Scale and Clinical Correlates

Presenter: Hannah Kempton

October 27, 2025

Presentation TCT 2025

Atrial Fixation Transcatheter Mitral Valve Replacement: 1- Year Outcomes of the AltaValve Early Feasibility Study

Presenter: Vlasis Ninios

October 27, 2025

Presentation TCT 2025

TCT 40: Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients with Cardiac Implantable Electronic Devices: Insights from the EuroTR Registry

Presenter: Jennifer von Stein

October 27, 2025

Presentation TCT 2025

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

Presenter: Himanshi Banker

October 27, 2025

Presentation TCT 2025

TCT 1115: Predictors of Mechanical Circulatory Support Use in Transcatheter Aortic Valve Replacement: Insights from a National Cohort

Presenter: Montaser Elkholy

October 27, 2025

Presentation TCT 2025

TCT 1119: Direct Comparison of Early Survival Following Urgent Transcatheter Aortic Valve Implantation Versus Balloon Aortic Valvuloplasty: A Systematic Review and Meta-Analysis

Presenter: Kyriakos Dimitriadis

October 27, 2025

Presentation TCT 2025

TCT 863: Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention

Presenter: Chloe Kharsa

October 27, 2025

Presentation TCT 2025

TCT 1118: Outcomes of Transcatheter Aortic Valve Replacement in Patients With Cardiogenic Shock: National Readmission Database Analysis

Presenter: Junaid Mir

October 27, 2025

Advertisement

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

TCT 46: Transcatheter Delivery of World’s Smallest Leadless Pacemakers for Cardiac Resynchronization Therapy

Percutaneous Transseptal Transcatheter Mitral Valve Replacement using a Dedicated Balloon Expandable Valve: 1 Year Outcomes from the ENCIRCLE Trial using the SAPIEN M3

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

TCT 717: Transcaval Transcatheter Aortic Valve Replacement: Safety and Feasibility in Routine Practice “The Vigo Experience”

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

TCT 36: Mid-term Outcomes of Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Replacement

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

TCT 38: Anemia Predicts Outcomes After Transcatheter Tricuspid Interventions

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

TCT 39: Hypo-Attenuated Leaflet Thickening After Transcatheter Tricuspid Valve Replacement: A Proposed Severity Scale and Clinical Correlates

Atrial Fixation Transcatheter Mitral Valve Replacement: 1- Year Outcomes of the AltaValve Early Feasibility Study

TCT 40: Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients with Cardiac Implantable Electronic Devices: Insights from the EuroTR Registry

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

TCT 1115: Predictors of Mechanical Circulatory Support Use in Transcatheter Aortic Valve Replacement: Insights from a National Cohort

TCT 1119: Direct Comparison of Early Survival Following Urgent Transcatheter Aortic Valve Implantation Versus Balloon Aortic Valvuloplasty: A Systematic Review and Meta-Analysis

TCT 863: Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention

TCT 1118: Outcomes of Transcatheter Aortic Valve Replacement in Patients With Cardiogenic Shock: National Readmission Database Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content